ArticleNeurosurgical review2026
Outcome predictors in older adults (≥ 65 years) with aneurysmal subarachnoid haemorrhage.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While advanced age is an established risk factor for poor outcomes in aneurysmal subarachnoid haemorrhage (aSAH), prognostic tools specific to older adults, remain limited. This study aims to characterise the utility of frailty indices, in addition to established outcome predictors, in older adults with aSAH. Cohort study of patients aged ≥ 65 years with aSAH referred from 2016 to 2022. Demographics, clinical, radiological and outcome data were recorded prospectively. Frailty indices were retrospectively assigned: the 5-item modified frailty index (mFI)-5, 11-item mFI (mFI-11), and electronic frailty index (EFI). 378 referred patients aged ≥ 65 years. 264/378 (69.84%) were transferred to a neurosurgical unit. 248/378 (65.61%) underwent aneurysm treatment (surgical 30/248, 12.09%; endovascular 218/248, 87.9%). 187/378 (49.47%) of referred and 66/248 (26.62%) of treated cases were poor World Federation of Neurosurgical Societies (WFNS) grade. Poor outcomes (death/dependence) occurred in 80/248 (32.26%) of treated cases. WFNS grades IV (adjusted odds ratio [aOR]: 5.08, 95% CI: 1.84–15.08) and V (aOR: 19.76, 95% CI: 5.78–74.18) were the strongest independent predictors of three-month mortality, followed by rebleeding (aOR: 5.93, 95% CI: 2.12–16.71), age (aOR: 1.10, 95% CI: 1.03–1.18), cerebrospinal fluid (CSF) diversion requirement (aOR: 3.11, 95% CI: 1.27–7.84) and the EFI (aOR: 1.23, 95% CI: 1.00-1.49). All WFNS grades independently predicted three-month functional status, particularly grades IV (aOR: 0.11, 95% CI: 0.05–0.25) and V (aOR: 0.03, 95% CI: 0.01–0.11). Additional independent predictors of three-month independence included the EFI (aOR: 0.77, 95% CI: 0.64–0.91), CSF diversion requirement (aOR: 0.39, 95% CI: 0.19–0.81), angiographic vasospasm (aOR: 0.44, 95% CI: 0.23–0.85), and age (aOR: 0.93, 95% CI: 0.88–0.99). WFNS grade was the most significant predictor of poor outcomes. The EFI emerged as a significant outcome predictor, however further study is required to fully determine the impact of frailty indices on outcomes in aSAH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.